Skip to main content

Kennedy Capital Management Llc

Source: SEC Form 13F · as of Mar 2026

Kennedy Capital Management Llc holds 47 biotech & pharma companies tracked by BioSniper, totaling $265.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

47

Total value held

$265.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for ANI PHARMACEUTICALS INC (ANIP)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ANIPANI PHARMACEUTICALS INC293,996$22.6M
PTGXProtagonist Therapeutics, Inc137,099$14.5M
COGTCogent Biosciences, Inc.360,490$13.9M
NAMSNEWAMSTERDAM PHARMA CO N.V.408,492$13.1M
ADPTAdaptive Biotechnologies Corp931,522$12.9M
GILDGILEAD SCIENCES, INC.91,264$12.7M
CLDXCelldex Therapeutics, Inc.352,302$11.2M
APGEApogee Therapeutics, Inc.122,669$10.3M
DAWNDay One Biopharmaceuticals, Inc.436,732$9.4M
AGIOAGIOS PHARMACEUTICALS, INC.275,456$9.3M
TECXTectonic Therapeutic, Inc.286,682$8.9M
NRIXNurix Therapeutics, Inc.561,250$8.7M
IONSIONIS PHARMACEUTICALS INC111,830$8.4M
XERSXeris Biopharma Holdings, Inc.1,240,692$7.2M
IRONDisc Medicine, Inc.108,286$6.9M
AXSMAxsome Therapeutics, Inc.36,775$6.2M
ORKAOruka Therapeutics, Inc.126,366$6.2M
ARVNARVINAS, INC.552,641$5.9M
AVTXAvalo Therapeutics, Inc.387,982$5.8M
RYTMRHYTHM PHARMACEUTICALS, INC.65,818$5.7M
PBYIPUMA BIOTECHNOLOGY, INC.889,601$5.7M
ABEOABEONA THERAPEUTICS INC.1,263,511$5.7M
INSMINSMED Inc34,526$5.6M
ANNXAnnexon, Inc.912,323$5.1M
RZLTRezolute, Inc.1,236,098$3.8M
ZYMEZymeworks Inc.148,226$3.7M
ADMAADMA BIOLOGICS, INC.411,347$3.7M
INCYIncyte Corp.36,429$3.4M
ROIVRoivant Sciences Ltd.121,897$3.4M
ARGXARGENX SE4,577$3.3M
JAZZJazz Pharmaceuticals plc17,603$3.3M
DSGNDesign Therapeutics, Inc.271,554$2.9M
HROWHARROW, INC.74,256$2.6M
SRRKScholar Rock Holding Corp37,452$1.8M
SNYSanofi36,982$1.8M
ABUSArbutus Biopharma Corp393,132$1.8M
NUVLNuvalent, Inc.11,909$1.2M
ALNYALNYLAM PHARMACEUTICALS, INC.3,503$1.2M
ABVXAbivax SA8,757$975K
CYTKCYTOKINETICS INC14,361$947K
SYRESpyre Therapeutics, Inc.16,873$851K
CGEMCullinan Therapeutics, Inc.51,491$732K
SIONSionna Therapeutics, Inc.12,284$492K
RNAAtrium Therapeutics Inc.33,977$454K
CADLCandel Therapeutics, Inc.92,625$454K
NTLAIntellia Therapeutics, Inc.29,424$377K
ALDXAldeyra Therapeutics, Inc.95,862$162K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.